AMA and Australian Government agree to strengthening the MBS review process and informed financial consent

8 June 2021 - The Australian Government and the Australian Medical Association have reached agreement to work together to co-design the ...

Read more →

Cancer expert to head review into efficient and equitable access to chemotherapy medicines

1 May 2021 - Renowned cancer expert Professor Sanchia Aranda AM will head an Australian Government review aimed at making ...

Read more →

Bristol Myers Squibb statement on FDA Advisory Committee meeting on Opdivo post sorafenib hepatocellular carcinoma U.S. indication

29 April 2021 - As part of its industry-wide review of accelerated approvals in oncology without confirmatory benefit, the U.S ...

Read more →

FDA Advisory Committee votes in favour of maintaining accelerated approval of Genentech’s Tecentriq for PD-L1 positive, metastatic triple negative breast cancer

27 April 2021 - Genentech today announced the U.S. FDA Oncologic Drugs Advisory Committee voted 7 to 2 in favour of ...

Read more →

Major health sector shake-up: Government scraps all district health boards in favour of one national authority

21 April 2021 - All of New Zealand's 20 District Health Boards will be replaced by one, single national health ...

Read more →

PHARMAC review misses political elephant in the room

13 March 2021 - The governments of many developed nations fund medicines for their citizens after they have gone through independent ...

Read more →

Pacific pharmacists want inclusion on PHARMAC review

6 March 2021 - The President of the Pacific Pharmacists’Association, Kasey Brown, says a review of New Zealand’s drug buying ...

Read more →

Cancer Society says PHARMAC review doesn't go far enough

3 March 2021 - A review of drug buying agency PHARMAC is being described as long overdue. ...

Read more →

The PHARMAC non-review?

4 March 2021 - The recently announced PHARMAC review is fatally flawed.  ...

Read more →

PHARMAC ripe for reassessment

3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...

Read more →

Government announces review into PHARMAC

2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...

Read more →

Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise

2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...

Read more →

Review asks how Government can get the new drugs it wants funded

2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...

Read more →

Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes

22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...

Read more →

TLV is tasked with reducing costs for medicines

16 February 2021 - The Government has commissioned the Swedish Dental and Pharmaceutical Benefits Agency, TLV, to implement measures to reduce ...

Read more →